Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells-Reference-Cited by-同舟云学术

Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells

Published:2018-08 Issue:8 Volume:14 Page:
ISSN:1744-4292
Container-title:Molecular Systems Biology
language:en
Short-container-title:Mol Syst Biol

Author:

Landry Benjamin D¹,Leete Thomas¹,Richards Ryan¹,Cruz‐Gordillo Peter¹^ORCID,Schwartz Hannah R¹,Honeywell Megan E¹^ORCID,Ren Gary¹,Schwartz Alyssa D²,Peyton Shelly R²,Lee Michael J¹^ORCID

Affiliation:

1. Program in Systems Biology Program in Molecular Medicine Department of Molecular, Cell and Cancer Biology University of Massachusetts Medical School Worcester MA USA

2. Department of Chemical Engineering University of Massachusetts Amherst MA USA

Funder

National Institute of General Medical Sciences

American Cancer Society

National Cancer Institute

Richard and Susan Smith Family Foundation

Breast Cancer Alliance

University of Massachusetts

Publisher

EMBO

Subject

Applied Mathematics,Computational Theory and Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Information Systems

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/msb.20188322

Reference40 articles.

1. The BCL-2 arbiters of apoptosis and their growing role as cancer targets

2. Molecular Classification of Triple-Negative Breast Cancer

3. Understanding and treating triple‐negative breast cancer;Anders C;Oncology (Williston Park),2008

4. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

5. Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models;Scientific Reports;2024-09-05

2. Engineered Biomaterials and Model Systems to Study YAP/TAZ in Cancer;ACS Biomaterials Science & Engineering;2024-08-27

3. The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer;Journal of Experimental & Clinical Cancer Research;2024-06-18

4. Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models;Coordination Chemistry Reviews;2024-06

5. Rational design of HER2-targeted combination therapies to reverse drug resistance in fibroblast-protected HER2+ breast cancer cells;2024-05-19